Estimating treatment effect heterogeneity for binary outcomes via Dirichlet multinomial constraints
From MaRDI portal
(Redirected from Publication:5122930)
Recommendations
- Individual treatment effects in randomized trials with binary outcomes.
- Assessing treatment effect heterogeneity in clinical trials with blocked binary outcomes
- Assessing the treatment effect heterogeneity with a latent variable
- Estimating the distribution of heterogeneous treatment effects from treatment responses and from a predictive biomarker in a parallel-group RCT: a structural model approach
- Unit–Treatment Interaction and Its Practical Consequences
Cited in
(8)- Individual treatment effects in randomized trials with binary outcomes.
- Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect
- Estimating the distribution of heterogeneous treatment effects from treatment responses and from a predictive biomarker in a parallel-group RCT: a structural model approach
- Estimation and Inference for the Causal Effect of Receiving Treatment on a Multinomial Outcome
- Assessing the treatment effect heterogeneity with a latent variable
- Assessing the heterogeneity of treatment effects by identifying the treatment benefit rate and treatment harm rate
- Using secondary outcome to sharpen bounds for treatment harm rate in characterizing heterogeneity
- Assessing treatment effect heterogeneity in clinical trials with blocked binary outcomes
This page was built for publication: Estimating treatment effect heterogeneity for binary outcomes via Dirichlet multinomial constraints
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5122930)
